Vertex Pharmaceuticals Incorporated
Patents, Design & Utilities
Last updated:
List of all Vertex Pharmaceuticals Incorporated patents 34 in total
| Status | Patent |
|---|---|
Grant | Utility: Modulator of the cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator Filling date: 17 Oct 2025 Issue date: 27 Sep 2022 |
Grant | Utility: Antiproliferation compounds and uses thereof Filling date: 17 Oct 2025 Issue date: 13 Sep 2022 |
Grant | Utility: Processes for preparing pyrrolidine compounds Filling date: 17 Oct 2025 Issue date: 6 Sep 2022 |
Grant | Utility: Materials and methods for treatment of myotonic dystrophy type 1 (DM1) and other related disorders Filling date: 17 Oct 2025 Issue date: 30 Aug 2022 |
Application | Utility: PHARMACEUTICAL COMPOSITIONS FOR TREATING CYSTIC FIBROSIS Filling date: 17 Oct 2025 Issue date: 18 Aug 2022 |
Grant | Utility: Modulators of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator Filling date: 17 Oct 2025 Issue date: 16 Aug 2022 |
Application | Utility: PHARMACEUTICAL COMPOSITION AND ADMINISTRATIONS THEREOF Filling date: 17 Oct 2025 Issue date: 4 Aug 2022 |
Application | Utility: PANCREATIC DIFFERENTIATION Filling date: 17 Oct 2025 Issue date: 28 Jul 2022 |
Application | Utility: COMPOUNDS USEFUL AS INHIBITORS OF ATR KINASE AND COMBINATION THERAPIES THEREOF Filling date: 17 Oct 2025 Issue date: 28 Jul 2022 |
Grant | Utility: Crystalline forms of C.sub.21H.sub.22Cl.sub.2N.sub.4O.sub.2 Filling date: 17 Oct 2025 Issue date: 19 Jul 2022 |
Grant | Utility: Materials and methods for treatment of Duchenne Muscular Dystrophy Filling date: 17 Oct 2025 Issue date: 28 Jun 2022 |
Application | Utility: METHODS OF TREATMENT FOR CYSTIC FIBROSIS Filling date: 17 Oct 2025 Issue date: 16 Jun 2022 |
Grant | Utility: Deuterated pyridone amides and prodrugs thereof as modulators of sodium channels Filling date: 17 Oct 2025 Issue date: 14 Jun 2022 |
Application | Utility: MACROENCAPSULATION DEVICES Filling date: 17 Oct 2025 Issue date: 9 Jun 2022 |
Application | Utility: MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS Filling date: 17 Oct 2025 Issue date: 19 May 2022 |
Application | Utility: MULTICOMPARTMENT MACROENCAPSULATION DEVICES Filling date: 17 Oct 2025 Issue date: 12 May 2022 |
Application | Utility: Mannose Derivatives for Treating Bacterial Infections Filling date: 17 Oct 2025 Issue date: 5 May 2022 |
Application | Utility: ESTERS AND CARBAMATES AS MODULATORS OF SODIUM CHANNELS Filling date: 17 Oct 2025 Issue date: 14 Apr 2022 |
Application | Utility: INHIBITORS OF APOL1 AND METHODS OF USING SAME Filling date: 17 Oct 2025 Issue date: 7 Apr 2022 |
Application | Utility: STEM CELL DERIVED ISLET DIFFERENTIATION Filling date: 17 Oct 2025 Issue date: 30 Dec 2021 |
Application | Utility: STEM CELL DERIVED ISLET DIFFERENTIATION Filling date: 17 Oct 2025 Issue date: 30 Dec 2021 |
Application | Utility: CRISPR/CAS Systems For Treatment of DMD Filling date: 17 Oct 2025 Issue date: 25 Nov 2021 |
Application | Utility: Solid Forms of (R)-1(2,2-Difluorobenzo[D][1,3]Dioxol-5-yl)-N-(1-(2,3-Dihydroxypropyl)-6-- Fluoro-2-(1-Hydroxy-2-Methylpropan-2-yl)-1H-Indol-5-yl)Cyclopropanecarboxa- mide Filling date: 17 Oct 2025 Issue date: 4 Nov 2021 |
Application | Utility: PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR MEDIATED DISEASES Filling date: 17 Oct 2025 Issue date: 7 Oct 2021 |
Application | Utility: METHODS OF TREATING APOL-1 DEPENDENT FOCAL SEGMENTAL GLOMERULOSCLEROSIS Filling date: 17 Oct 2025 Issue date: 9 Sep 2021 |
Application | Utility: METHODS OF TREATMENT FOR ALPHA-1 ANTITRYPSIN DEFICIENCY Filling date: 17 Oct 2025 Issue date: 26 Aug 2021 |
Application | Utility: SOLID FORMS OF N-[2,4-BIS(1,1-DIMETHYLETHYL)-5-HYDROXYPHENYL]-1,4-DIHYDRO-4-OXOQUINOLINE- -3-CARBOXAMIDE Filling date: 17 Oct 2025 Issue date: 19 Aug 2021 |
Application | Utility: SOLID FORMS OF APOL1 INHIBITOR AND METHODS OF USING SAME Filling date: 17 Oct 2025 Issue date: 12 Aug 2021 |
Application | Utility: PROCESSES FOR MAKING MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR Filling date: 17 Oct 2025 Issue date: 12 Aug 2021 |
Application | Utility: STEM CELL DERIVED ISLET DIFFERENTIATION Filling date: 17 Oct 2025 Issue date: 5 Aug 2021 |
Application | Utility: SUBSTITUTED QUINOXALINE DNA-PK INHIBITORS Filling date: 17 Oct 2025 Issue date: 5 Aug 2021 |
Application | Utility: PROCESS OF PRODUCING CYCLOALKYLCARBOXAMIDO-INDOLE COMPOUNDS Filling date: 17 Oct 2025 Issue date: 5 Aug 2021 |
Application | Utility: COMPOSITIONS FOR TREATING CYSTIC FIBROSIS Filling date: 17 Oct 2025 Issue date: 29 Jul 2021 |
Grant | Utility: Inhibitors of influenza viruses replication Filling date: 17 Oct 2025 Issue date: 29 Dec 2020 |
Showing 1 to 34 of 34 patents.